People: argenx SE (ARGX.OQ)

ARGX.OQ on NASDAQ Stock Exchange Global Select Market

6 Jul 2020
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Verhaeghe, Peter 

Mr. Peter K. M. Verhaeghe serves as Non-Executive Independent Chairman of the Board of the Company. He has served as a member and chairperson of the supervisory board of arGEN-X B.V. since October 2008 and as non-executive director on the Company's board of directors since July 2014. Mr. Verhaeghe is the managing partner of VVGB Advocaten—Avocats, a corporate finance law and tax law firm, a position he has held since July 1999. He is currently lead counsel to a number of Belgian, Dutch and Swiss biotechnology and diagnostics companies. Mr. Verhaeghe served as the president of the board of directors of Meri-sant France SAS, as a member of the management board of Merisant Company 2 sarl and serves as a member of the board of directors of CzechPak Manufacturing s. r. o. He previously served as the chairman of the board of directors of PharmaNeuroBoost NV from December 2006 to January 2013 and as liquidator in charge of KBC Private Equity Fund Biotech NV from April 2009 to December 2012. Mr. Verhaeghe holds a degree in law from Katholieke Universiteit Leuven, 1981, and an LLM degree from Harvard Law School of Harvard University, 1984. He is Member of the Audit Committee, and Member of the Remuneration and Nomination Committee of the Company.

Basic Compensation

Total Annual Compensation, EUR 734,670
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 734,670

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --